Kyung Ah Jung

Title: Kyung Ah Jung: Innovator in Cancer Treatment

Introduction

Kyung Ah Jung is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic compositions.

Latest Patents

Kyung Ah Jung holds a patent for a composition aimed at the treatment or metastasis suppression of cancers. This composition includes a p34 expression inhibitor or activity inhibitor as an active ingredient. The invention highlights that the knock-down of the p34 protein leads to monoubiquitination of PTEN, which induces its nuclear localization. This process inhibits the Akt pathway associated with tumor survival, proliferation, and metastasis. As a result, the invention demonstrates a significant reduction in the clonogenic potential and tumor-forming ability of various cancer cells that express both PTEN and NEDD4-1. The p34 gene expression inhibitor or p34 protein activity inhibitor can be effectively utilized as a treatment or metastasis suppression agent for cancers.

Career Highlights

Throughout her career, Kyung Ah Jung has worked with notable organizations, including the Asan Foundation and the University of Ulsan Foundation for Industry Cooperation. Her work has been instrumental in advancing cancer research and treatment methodologies.

Collaborations

Kyung Ah Jung has collaborated with various professionals in her field, including her coworker Dong Hoon Jin. Their joint efforts have contributed to the development of innovative solutions in cancer treatment.

Conclusion

Kyung Ah Jung's contributions to cancer treatment through her innovative patent and collaborations highlight her dedication to advancing medical science. Her work continues to inspire future research in the field of oncology.